The Edinburgh-based ceramics expert, 38, reflected on her health and 'how she's feeling about things' in a candid new article ...

Newly discovered targets may hold the key to effectively treating glioblastoma, a deadly form of brain cancer. These targets ...

A Lisbon man is battling a rare brain cancer. It’ll be a long road to recovery and the treatment is going to be costly.

Targeting and customizing blood vessels in tumors to increase T cell infiltration and maintain their function may represent the next breakthrough in cancer therapy.

A research team at Lund University in Sweden has discovered a certain type of cell—foam cells—in patients with the aggressive ...

Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis—the average survival ...

Researchers have identified potential drug targets in glioblastoma cancer stem cells, providing a new approach to treat this ...

As a surgical strategy for the management of glioblastoma, lobectomy improves overall survival and PFS by approximately 1 year, demonstrating its promise.

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively ...

Walkers and runners laced up their shoes in Richmond on Sunday, with every stride getting them one step closer to helping ...

Glioblastoma, a highly aggressive brain cancer, poses survival challenges with current treatments like surgery and chemotherapy. Immunotherapy offers hope by leveraging the immune system against ...

Q3 2024 Earnings Call Transcript October 30, 2024 NovoCure Limited beats earnings expectations. Reported EPS is $-0.28, expectations were $-0.34. Operator: Good day, and thank you for standing by.